| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2017) |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| ATC: | H05AA04 |
| UNII: | AVK0I6HY2U |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Parathyroid hormone receptor agonist | FDA |
| Primary Target | |
|---|---|
| PTH1 receptor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
Family B G protein-coupled receptor
Peptide receptor (family B GPCR)
Parathyroid hormone receptor
Parathyroid hormone receptor
|
0 | - | - | - | - |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Osteoporosis, Postmenopausal | 3 | D015663 | ClinicalTrials |
| Fractures, Bone | 2 | D050723 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 247062-33-5 |
| ChEMBL | CHEMBL3301581 |
| FDA SRS | AVK0I6HY2U |
| Guide to Pharmacology | 8299 |
| PubChem | 76943386 |
CONTENTS